Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 98, Issue , 2016, Pages 57-66

  Aroso, Ivo M ^a   Silva, João C ^a   Mano, Francisca ^b   Ferreira, Ana S D ^b,c   Dionísio, Madalena ^b   Sá Nogueira, Isabel ^b   Barreiros, Susana ^b   Reis, Rui L ^a   Paiva, Alexandre ^b   Duarte, Ana Rita C ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Drug solubility; Green technologies; Pharmaceutical and biomedical applications; Therapeutic deep eutectic systems

Indexed keywords

ACETYLSALICYLIC ACID; BENZOIC ACID; CHOLINE; DRUG SOLVENT; MENTHOL; PHENYLACETIC ACID; THERAPEUTIC DEEP EUTECTIC SOLVENT; UNCLASSIFIED DRUG; DRUG VEHICLE; SOLVENT;

ARTICLE; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; COMPARATIVE STUDY; CONJUGATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SYNTHESIS; ESCHERICHIA COLI K 12; HYDROGEN BOND; IN VIVO STUDY; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; THERMAL ANALYSIS; DRUG FORMULATION; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; MAGNETIC RESONANCE SPECTROSCOPY; PHARMACEUTICAL VEHICLES; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84948154284     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.11.002     Document Type: Article

References (26)

1. S. Cherukuvada, and A. Nangia Eutectics as improved pharmaceutical materials: design, properties and characterization Chem. Commun. 50 8 2014 906 923
2. Y.T. Dai Natural deep eutectic solvents as new potential media for green technology Anal. Chim. Acta 766 2013 61 68
3. A. Paiva Natural deep eutectic solvents - solvents for the 21st century ACS Sustain. Chem. Eng. 2 5 2014 1063 1071
4. E.L. Smith, A.P. Abbott, and K.S. Ryder Deep Eutectic Solvents (DESs) and their applications Chem. Rev. 114 21 2014 11060 11082
5. P.W. Stott, A.C. Williams, and B.W. Barry Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen J. Control. Release 50 1-3 1998 297 308
6. H.G. Morrison, C.C. Sun, and S. Neervannan Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles Int. J. Pharm. 378 1-2 2009 136 139
7. S. Tuntarawongsa, and T. Phaechamud Polymeric eutectic system Front. Nanosci. Technol. II 528 2012 180 183
8. S. Tuntarawongsa, and T. Phaechamud Menthol, borneol, camphor and WS-3 EUTECTIC MIXTURE Biomater. Appl. 506 2012 355 358
9. K. Bica Pharmaceutically active ionic liquids with solids handling, enhanced thermal stability, and fast release Chem. Commun. 48 44 2012 5422 5424
10. R. dos Santos Development of antimicrobial Ion Jelly fibers RSC Adv. 3 46 2013 24400 24405
11. H. Wang Simultaneous membrane transport of two active pharmaceutical ingredients by charge assisted hydrogen bond complex formation Chem. Sci. 5 9 2014 3449 3456
12. R. Craveiro et al., THEDES - Therapeutic deep eutectic solvents: new solvents for the functionalization of natural-based polymers, in: 14th European Meeting on Supercritical Fluids, 2014, Marseille.
13. M. Martins Enhanced performance of supercritical fluid foaming of natural-based polymers by deep eutectic solvents AIChE J. 60 11 2014 3701 3706
14. I.M. Aroso Design of controlled release systems for THEDES - therapeutic deep eutectic solvents, using supercritical fluid technology Int. J. Pharma. 492 1-2 2015 73 79
15. M. Prime, R.B. Prime, Analysis of Polymers, Fundamentals and Applications, 2009, Hoboken, New Jersey.
16. J.H. Miller Experiments in molecular genetics 1972 Cold Spring Harbor Laboratory Cold Spring Harbor, NY
17. J.M. Andrews Determination of minimum inhibitory concentrations J. Antimicrob. Chemother. 48 2001 5 16
18. S.L. Perkins, P. Painter, and C.M. Colina Experimental and computational studies of choline chloride-based deep eutectic solvents J. Chem. Eng. Data 59 11 2014 3652 3662
19. H. Yamashita Coformer screening using thermal analysis based on binary phase diagrams Pharm. Res. 31 8 2014 1946 1957
20. P. Costa, J. Manuel, and S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2 2001 123 133
21. D. Trombetta Mechanisms of antibacterial action of three monoterpenes Antimicrob. Agents Chemother. 49 6 2005 2474 2478
22. S. Cherukuvada, and T.N.G. Row Comprehending the formation of eutectics and cocrystals in terms of design and their structural interrelationships Cryst. Growth Des. 14 8 2014 4187 4198
23. Y. Kawabata Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications Int. J. Pharm. 420 1 2011 1 10
24. N. Schultheiss, and A. Newman Pharmaceutical cocrystals and their physicochemical properties Cryst. Growth Des. 9 6 2009 2950 2967
25. B.K. Hwang Isolation and in vivo and in vitro antifungal activity of phenylacetic acid and sodium phenylacetate from Streptomyces humidus Appl. Environ. Microbiol. 67 8 2001 3739 3745
26. A.F. Sanchez-Maldonado, A. Schieber, and M.G. Ganzle Structure-function relationships of the antibacterial activity of phenolic acids and their metabolism by lactic acid bacteria J. Appl. Microbiol. 111 5 2011 1176 1184